- Home
- AXSM vs GMED Comparison
AXSM vs GMED Comparison
Compare AXSM & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AXSM | GMED |
|---|---|---|
| Founded | 2012 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.9B |
| IPO Year | 2015 | 2012 |
Fundamental Metrics
Financial Performance| Metric | AXSM | GMED |
|---|---|---|
| Price | $236.31 | $78.16 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 14 |
| Target Price | ★ $211.12 | $100.42 |
| AVG Volume (30 Days) | 878.2K | ★ 1.9M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 38.56 | ★ 422.67 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $57.24 | $11.13 |
| Revenue Next Year | $55.88 | $6.28 |
| P/E Ratio | ★ N/A | $84.27 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $96.09 | $51.79 |
| 52 Week High | $260.19 | $101.40 |
Technical Indicators
Market Signals| Indicator | AXSM | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 47.92 | 47.60 |
| Support Level | $236.44 | $75.53 |
| Resistance Level | $256.40 | $86.21 |
| Average True Range (ATR) | 9.67 | 3.51 |
| MACD | -2.09 | -0.14 |
| Stochastic Oscillator | 42.72 | 33.00 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About GMED Globus Medical Inc.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.